Cargando…
miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma
Thyroid cancer incidence is rapidly increasing. Papillary Thyroid Carcinoma (PTC), the most frequent hystotype, usually displays good prognosis, but no effective therapeutic options are available for the fraction of progressive PTC patients. BRAF and RET/PTC are the most frequent driving genetic les...
Autores principales: | Minna, Emanuela, Romeo, Paola, De Cecco, Loris, Dugo, Matteo, Cassinelli, Giuliana, Pilotti, Silvana, Degl'Innocenti, Debora, Lanzi, Cinzia, Casalini, Patrizia, Pierotti, Marco A., Greco, Angela, Borrello, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058023/ https://www.ncbi.nlm.nih.gov/pubmed/24810336 |
Ejemplares similares
-
Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas
por: Degl'Innocenti, Debora, et al.
Publicado: (2010) -
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2016) -
Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
por: Minna, Emanuela, et al.
Publicado: (2018) -
Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity
por: Lanzi, Cinzia, et al.
Publicado: (2018) -
The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer
por: Colombo, Carla, et al.
Publicado: (2020)